Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

4.10
-0.0350-0.85%
Post-market: 4.100.00000.00%16:15 EDT
Volume:596.82K
Turnover:2.47M
Market Cap:264.41M
PE:-4.18
High:4.23
Open:4.16
Low:4.09
Close:4.13
52wk High:8.48
52wk Low:3.86
Shares:64.57M
Float Shares:49.21M
Volume Ratio:1.05
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9796
EPS(LYR):-1.2729
ROE:-52.15%
ROA:-32.77%
PB:1.39
PE(LYR):-3.22

Loading ...

Immuneering Presents AACR Data Linking Atebimetinib Plus mGnP to Longer Survival in Pancreatic Cancer Study

Reuters
·
Sep 28

Immuneering MAPKeeper-301 Phase 3 Pancreatic Cancer Trial Abstract Wins ESMO 2026 Poster Slot

Reuters
·
Sep 24

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

GlobeNewswire
·
Sep 10

Immuneering to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 04

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

TIPRANKS
·
Aug 27

Immuneering Enrolls Phase 3 MAPKeeper 301 Trial of Atebimetinib Combo in First-Line Metastatic Pancreatic Cancer

Reuters
·
Aug 27

aTyr Pharma Q2 Net Loss Narrows

Reuters
·
Aug 08

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

MT Newswires Live
·
Aug 06

Immuneering Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 06

Immuneering Corporation : H.c. Wainwright Initiates Coverage with Buy Rating

THOMSON REUTERS
·
Aug 06

Arcus Biosciences Q2 Revenue Falls Sharply on Lower License Income

Reuters
·
Aug 06

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments

Reuters
·
Aug 06

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

Reuters
·
Aug 06

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Immuneering Q2 EPS $(0.27), Inline

Benzinga Earnings
·
Aug 05

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 05

Immuneering publishes preclinical data on atebimetinib in Cancer Research

TIPRANKS
·
Jul 22

Immuneering Flags New Press Release on Atebimetinib Preclinical Study Publication in Cancer Research

Reuters
·
Jul 22